Member Info for PhatStyle4321

I agree, at these prices we are at a huge discount on what this is worth. £1 plus is fair value, once profit kicks in, the dividends will shortly follow

I have loads of shares in this, just saying how it is

This situation is not going to be solved quick and is going to drag us right down

https://www.google.co.uk/amp/s/www.aljazeera.com/amp/news/2020/10/3/fresh-clashes-erupt-in-nagorno-karabakh-for-seventh-day

Fresh fighting erupts dashing hopes for cease fire

https://www.google.co.uk/amp/s/www.dailymail.co.uk/news/article-8800917/amp/Azerbaijan-releases-new-aerial-footage-claiming-bombing-raid-Armenian-soldiers.html

Doesn’t not bode well for the Company at all, will be more selling going into Xmas

4D tweeted than removed? Have they accidentally tweeted more good news on our cancer forefront ? Who knows

Very strange. Now removed
5m
@4dpharmaplc

#DDDD $DDDD will present not 1 but 2 posters at
@sitcancer

#SITC2020 9-14 Nov. Presenting our Phase I/II study of #livebiotherapeutic MRx0518 + #Keytruda in #cancer patients refractory to immune checkpoint inhibitors
#oncology #DDDD

Can try and recoup losses with 4d Pharma with news expected next week which could rocket the share price

I think we will get a lot higher today. Fantastic news is about to drop on Monday that will propel the value of this company into Orbit, the first phase 2 published

The news from OPTI, emphasises that this is such an undervalued sector and the benefits of shareholders are about to be huge. This new kind of health benefits will be worth billions, all the advantages without the disadvantages, last day to get your hands on cheap shares

Great news for the company, share price is too low IMO

Company has confirmed the Blautix news will arrive in the first few days of October, that means a monster RNS Monday morning! Last day to buy shares everyone before the transformational change

https://www.businesswire.com/news/home/20200930005199/en/Vedanta-Biosciences-Awarded-Up-to-76.9-Million-Including-7.4-Million-Upfront-from-BARDA-to-Advance-the-Development-of-VE303-a-Defined-Bacterial-Consortium-for-Prevention-of-C.-difficile-Infection-in-High-Risk-Patients

£7.4m upfront payment, and £77 m awarded, any partner joining 4D will be paying a huge upfront cost to have the worlds first IBS treatment, more validation for 4D is at the forefront out. Expect huge buying tomorrow. Have a great night all

Once news has arrived this has the potential to become a billion pound company this month. A cure for IBS is literally company changing and the wording used in the RNS that it has the potential for the worlds first cure is giving us a hint what to expect. The cancer results were mind blowing and coupled with IBS we really do have a winner

Looks like MM’s phishing for shares, they play their own tactics and let them. We all know for sure how undervalued this company is compared to its peers. Round the corner we have the IBS read outs which is going to propel us on another platform. Potential for the worlds first treatment, now that is something. Either tomorrow or Monday could be the big day. The company want to get the news out asap but everyone knows that a big jump is coming

This just seems healthy consolidation before the breakout towards £2. News is imminent and it’s going to blast

I think we can expect news Monday morning, which gives 2 more days buying more shares. IBS is an under treated condition and this will be the worlds first. The value here is astronomical. If anyone knows how bad living with IBS is they will also know any kind of treatment will be in high demand due to the life destroying nature of the condition. Thousands of companies on the stock market but happy to have my money invested in a company that saves peoples lives. GLA

We are going to break over £2 shortly, Seres just keeps booming and we have a lot of catching up to do

These results are going to be huge, the hint was in the interim results, I feel that this will be the first official treatment for IBS. There is no way there can be bad results from this

The trial has now completed enrolment of approximately 370 patients and 4D pharma expects to announce full topline results in the first few days in Q4. Blautix® has the potential to be the world's first disease modifying therapy for IBS, by treating the underlying microbiome cause of disease.

One last day to get on board before the company blasts into orbit, all indicators points to there being great results, time will tell, 4D isn’t a one trick pony and if the previous poster was correct about knowing the news is good then there is no risk. I am going to top up today to double my holding on any weakness